Ansell: A complete product offering
Scott Power
Morgans
Ansell continues to expand its product portfolio in the personal protection equipment (PPE) space with a US$88m acquisition of UK-headquartered chemical protective clothing manufacturer Microgard. While we view the FY16 accretive deal as an incremental positive, market conditions remain challenging, integration risk should not be overlooked and trading levels reflect fair value. We increase our FY15-17 EBIT between 0.2-3.1%. We raise our DCF/SOP-based price target to A$29.26 (prior A$29.20) and maintain our Hold rating.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media.
I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these sectors, which help with identification of key trends and developments.
1 topic
1 stock mentioned
Scott Power
Senior Analyst
Morgans
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Scott Power
Senior Analyst
Morgans
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
The 7 zombie companies lurking on the ASX 300
Livewire Markets